MeiraGTx to receive up to $375 million in non-dilutive cash and up to $25 million in equity investmentFollowing regulatory approval, Oberland ...
A new laser technique decodes molecular vibrations to predict whether a drug will be effective, potentially cutting years ...
2h
Ealing Council sets aside £1.4m to give its high streets makeover - the areas most likely to get it
Ealing Council has announced its own £1.4million 'Pride in Place' programme to upgrade high streets after the borough was ...
Certain medicines contain per- and polyfluorinated alkyl compounds, known as PFAS, which are causing increasing environmental ...
Good morning, everyone, and welcome to Part 1 of Arrowhead Pharmaceuticals' 2026 Summer Series of R&D webinars. [Operator Instructions] As a reminder, this call is being recorded, and a replay will be ...
A guide to the laws Iowa's rolling out July 1, 2026 ...
CRISPR Therapeutics wins FDA pediatric approval for Casgevy, boosting market potential and pipeline upside despite slow uptake. Click here to read more.
Senior leaders and scientists from DuPont toured several core facilities and learned about UD’s advanced materials characterization and unique testing capabilities, from analytical techniques for 3D ...
TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the initiation of a Phase 2 clinical trial evaluating BRIUMVI® (ublituximab-xiiy), in adults with treatment-resistant schizophrenia. The Phase 2 ...
Neuroprogressive disorders, particularly Alzheimer’s disease and schizophrenia, are increasingly recognized as multifactorial conditions involving chronic ...
Introduction Psychotic disorders account for significant morbidity and healthcare costs and yet their pathophysiology remains poorly understood. The National Institute for Health and Care Research ...
Lipid-based nanocarriers, particularly liposomes, have played a central role in the development of modern drug delivery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results